Tri-Point's surgical adhesive cleared in Canada
This article was originally published in Clinica
Executive Summary
Tri-Point Medical LP (US) has received clearance from the Canadian Ministry of Health and Welfare to market its wound- closure adhesive, Traumaseal. The biocompatible adhesive can be used to close wounds from skin lacerations, minimally invasive surgery and plastic surgery. No anaesthesia is required to apply the liquid suture and procedure time is "minimal", says Tri-Point. US FDA export approval has been granted for the product which will be distributed in Canada by Pilling Weck (US).
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.